Medicines and Healthcare products Regulatory Agency

MANUFACTURER'S AUTHORISATION
1: Authorisation Number UK MIA(IMP) 46113
2: Name of authorisation holder AUTOLUS LIMITED
3: Address(es) of manufacturing site(s)

AUTOLUS LIMITED MODULE 4, MODULE 4, CELL & GENE THERAPY CATAPULT MANUFACTURING CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2FX, UNITED KINGDOM

AUTOLUS LIMITED THE NUCLEUS, THE NUCLEUS, MARSHGATE, STEVENAGE, SG1 1FR, UNITED KINGDOM

AUTOLUS LIMITED MODULE 3, MODULE 3, CELL & GENE THERAPY CATAPULT MANUFACTURING CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2FX, UNITED KINGDOM

4: Legally registered address of authorisation holder AUTOLUS LIMITED, THE MEDIAWORKS, 191 WOOD LANE, LONDON, W12 7FP, UNITED KINGDOM
5: Scope of authorisation and dosage forms ANNEX 1 and/ or ANNEX 2
6: Legal Basis of authorisation
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation Confidential
8: Authorisation Date 18/03/2024
9: Annexes attached Annex 1 and/or Annex 2
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:

AUTOLUS LIMITED MODULE 4, MODULE 4, CELL & GENE THERAPY CATAPULT MANUFACTURING CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2FX, UNITED KINGDOM

Human Investigational Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.1 ] Sterile Investigational Medicinal Products
    [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms)
        [ 1.1.1.1 ] Large volume liquids
            Special Requirements
            Live Cells
        [ 1.1.1.4 ] Small volume liquids
            Special Requirements
            Live Cells
        [ 1.1.1.6 ] Other aseptically prepared products
            Gene Therapies
            Special Requirements
            Live Cells
    [ 1.1.3 ] Batch certification
[ 1.3 ] Biological investigational medicinal products
    [ 1.3.1 ] Biological medicinal products
        [ 1.3.1.4 ] Gene therapy products
            Special Requirements
            Live Cells
    [ 1.3.2 ] Batch certification
        [ 1.3.2.4 ] Gene therapy products
            Special Requirements
            Live Cells
[ 1.5 ] Packaging
    [ 1.5.2 ] Secondary packaging
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:

AUTOLUS LIMITED THE NUCLEUS, THE NUCLEUS, MARSHGATE, STEVENAGE, SG1 1FR, UNITED KINGDOM

Human Investigational Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.1 ] Sterile Investigational Medicinal Products
    [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms)
        [ 1.1.1.1 ] Large volume liquids
            Special Requirements
            Live Cells
        [ 1.1.1.4 ] Small volume liquids
            Special Requirements
            Live Cells
        [ 1.1.1.6 ] Other aseptically prepared products
            Gene therapies
    [ 1.1.3 ] Batch certification
[ 1.3 ] Biological investigational medicinal products
    [ 1.3.1 ] Biological medicinal products
        [ 1.3.1.4 ] Gene therapy products
            Special Requirements
            Live Cells
    [ 1.3.2 ] Batch certification
        [ 1.3.2.4 ] Gene therapy products
            Special Requirements
            Live Cells
[ 1.5 ] Packaging
    [ 1.5.2 ] Secondary packaging
[ 1.6 ] Quality control testing
    [ 1.6.1 ] Microbiological: sterility
    [ 1.6.2 ] Microbiological: non-sterility
    [ 1.6.4 ] Biological
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:

AUTOLUS LIMITED MODULE 3, MODULE 3, CELL & GENE THERAPY CATAPULT MANUFACTURING CENTRE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2FX, UNITED KINGDOM

Human Investigational Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.1 ] Sterile Investigational Medicinal Products
    [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms)
        [ 1.1.1.6 ] Other aseptically prepared products
            Ex Vivo Viral Vector
[ 1.3 ] Biological investigational medicinal products
    [ 1.3.1 ] Biological medicinal products
        [ 1.3.1.4 ] Gene therapy products
            Special Requirements
            Ex Vivo Viral Vector
[ 1.4 ] Other investigational medicinal products or manufacturing activitiy
    [ 1.4.2 ] Sterilisation of active substances/excipients/finished products:
        [ 1.4.2.1 ] Filtration